Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT-CYB pseudogene 36 (MTCYBP36) is described in gene databases as a pseudogene related to the mitochondrial MT-CYB locus and has no protein-coding function, biological activity, or direct connection to any disease mechanism or therapeutic intervention. It is a non-functional, non-protein-coding DNA segment resembling the functional mitochondrially encoded cytochrome b gene (MT-CYB), and does not participate in mitochondrial electron transport, encode a receptor, enzyme, or signaling molecule, nor is it implicated as a biomarker or drug target. It is not a functional drug or disease target but rather a genomic pseudogene. There are no reports in the scientific or clinical literature suggesting this pseudogene has a biological or pathological role, nor is it targeted by any drugs or used in patient selection. If you are seeking information on the functional, mitochondrial Complex III cytochrome b (MT-CYB gene), please specify, as that locus is biologically and therapeutically significant.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MT-CYB pseudogene 36 (MTCYBP36).